24/7 Emergency & General Advisory
π¨ 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM β 6:00 PM, MonβSat
For appointments & general queries.
Join our healthcare community
Stay updated with our latest healthcare news and your appointments.
A comprehensive guide to Mavenclad (cladribine) for managing relapsing forms of Multiple Sclerosis (MS) in India. Learn about its uses, dosage, side effects, and when to consult a doctor.

Multiple Sclerosis (MS) is a complex neurological condition that can significantly impact an individual's life. For those in India dealing with relapsing forms of MS, understanding treatment options is paramount. Today, we're diving deep into Mavenclad, a prescription medication containing cladribine, which offers a new avenue for managing this chronic disease. While not a cure, Mavenclad aims to reduce the frequency and severity of relapses, offering a glimmer of hope and improved quality of life for many.
Mavenclad is an oral medication, meaning you swallow it as a tablet. It's not available in a generic form, making it a unique treatment option. The active ingredient, cladribine, is believed to work by reducing the number of lymphocytes in your body. Lymphocytes are a type of white blood cell that plays a role in your immune system. In MS, the immune system mistakenly attacks the myelin sheath β the protective covering around nerve fibers in the brain and spinal cord. By lowering lymphocyte levels, Mavenclad may help to calm this immune response, thereby easing MS symptoms and lowering the chances of experiencing a relapse.
It's important to understand that Mavenclad is prescribed for specific types of MS. It is indicated for adults with relapsing forms of multiple sclerosis. This includes relapsing-remitting MS (RRMS), where individuals experience periods of symptom flare-ups (relapses) followed by periods of recovery (remission), and active secondary progressive MS (SPMS), where symptoms persist and worsen over time without distinct remission periods.
A key point to remember is that Mavenclad is generally considered for individuals whose MS has not responded adequately to other treatments or who have experienced troublesome side effects from previous therapies. It's not a first-line treatment, but rather a valuable option when other avenues have been explored.
Mavenclad is specifically prescribed for adults diagnosed with certain types of relapsing multiple sclerosis. These include:
It is crucial to note that Mavenclad is not recommended for treating clinically isolated syndrome (CIS). CIS is often the first neurological episode a person might experience, and it may or may not progress to MS. Your neurologist will make the final decision on whether Mavenclad is the right choice for your specific situation.
The way Mavenclad is administered is quite distinct from many other MS medications. It's given in two courses, separated by a significant time interval. Each course involves taking the tablets orally for a specific number of days.
Following the completion of both these courses, you generally won't take Mavenclad again for at least 2 years. This extended dosing schedule is designed to provide a long-lasting effect. The total treatment duration is typically limited to two courses over a period of up to four years. Your doctor will monitor you closely throughout this period.
Taking any medication requires careful attention to instructions, and Mavenclad is no exception. Always follow your doctor's guidance precisely. Here are some key points:
Like all medications, Mavenclad can cause side effects. While serious side effects are not common, it's essential to be aware of them and know when to seek medical help. Your doctor will discuss these with you in detail before you start treatment.
Some individuals may experience:
While rare, serious side effects can occur. Call your doctor immediately if you experience any of the following:
If you believe you are experiencing a medical emergency, call your local emergency number (like 108 or 112 in India) or go to the nearest emergency room immediately.
It's vital to inform your doctor about all the medications you are currently taking, including over-the-counter drugs, vitamins, and herbal supplements. Certain medications can interact with Mavenclad, potentially affecting its efficacy or increasing the risk of side effects. For example, other medications that suppress the immune system or increase the risk of infection should be used with caution.
Mavenclad is not recommended for use during pregnancy or if you are breastfeeding. Furthermore, if you can become pregnant or have a sexual partner who can become pregnant, you must use effective birth control while taking Mavenclad and for at least 6 months after your last dose. Discuss your family planning goals with your doctor before starting this medication.
While Mavenclad is a significant treatment, managing MS is a holistic process. Alongside medication, lifestyle factors play a crucial role:
It's essential to maintain regular contact with your neurologist and healthcare team. You should consult your doctor:
Navigating life with Multiple Sclerosis can be challenging, but with the right information and medical support, managing the condition effectively is possible. Mavenclad represents a significant advancement in treatment options for relapsing forms of MS, offering hope and a pathway to a better quality of life for many individuals in India.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Visit Hospital
Near You

Can a simple blood draw really predict dementia decades before memory problems start? In 2026, several major studies said yes β one found a protein called p-tau217 predicted risk up to 25 years ahead in women, while another found a 78% risk of cognitive impairment within 10 years in people with the
July 23, 2026

Learn about Parkinson's disease symptoms, causes, stages, and treatment options. A complete guide for patients and caregivers in simple language.
June 13, 2026
Seeking a brain specialist in Kamarhati? Doctar connects you with leading neurologists and neurosurgeons for expert care. Book appointments now.
May 20, 2026